In real life, one-quarter of patients with hormone receptor-positive metastatic breast cancer receive chemotherapy as initial palliative therapy: a study of the Southeast Netherlands Breast Cancer Consortium

D.J.A. Lobbezoo, R.J.W. van Kampen, A. C. Voogd, M. W. Dercksen, F. van den Berkmortel, T. J. Smilde, A. J. van de Wouw, F. P. J. Peters, J. M. G. H. van Riel, N. A. J. B. Peters, M. de Boer, P. G. M. Peer, V. C. G. Tjan-Heijnen

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)256-262
Number of pages7
JournalAnnals of Oncology
Volume27
Issue number2
DOIs
Publication statusPublished - Feb 2016

Keywords

  • metastatic breast cancer
  • chemotherapy
  • endocrine therapy
  • outcome
  • hormone receptor

Cite this